80%Confidence
0Views
SEC EDGARSource
2026-04-08Date
Summary
Mirum Pharmaceuticals has filed an amended 8-K (8-K/A), which typically corrects or supplements previously disclosed information, potentially addressing material updates to prior announcements. This amendment may involve financial restatements, executive changes, or other significant corporate events that require investor attention.
Actionable: Compare the amended 8-K with the original filing to identify changes and assess their impact on Mirum's financial or operational standing.
AI Confidence: 80%
Data Points
companyMirum Pharmaceuticals, Inc. (MIRM) (CIK 0001759425)
form8-K
date2026-04-08
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now